EXELA
Live / Registered — Registered (as of 15 Nov 2022)
What this means for you
Registered since 15 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90792345
- Registration number
- 6898483
- Mark type
- Word mark
- Filed
- 24 Jun 2021
- Published for opposition
- 30 Aug 2022
- Registered
- 15 Nov 2022
- Attorney of record
- Laura M. Konkel
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and immune system diseases and disorders, excluding pharmaceuticals that are directly targeted for the treatment of cancer
- Class 035 — Advertising and business services: Marketing services
- Class 040 — Treatment of materials: Manufacture of pharmaceutical products for others
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- Exela Holdings, Inc., Lenoir, NC, US
- Exela Holdings, Inc., Lenoir, NC, US
- Exela Holdings, Inc., Lenoir, NC, US
Prior registrations
Prosecution history
- 15 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Aug 2022 — PUBLISHED FOR OPPOSITION
- 10 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Apr 2022 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 19 Apr 2022 — PRIORITY ACTION E-MAILED
- 19 Apr 2022 — PRIORITY ACTION WRITTEN
- 12 Apr 2022 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 29 Mar 2022 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 17 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER